Biznes - artykuły archiwalne

  • 14.12.2013
    BIND Therapeutics Inc, przedsiębiorstwo nanomedyczne zajmujące się terapeutyką o nazwie AccurinsTM, ogłosiło dzisiaj, że zostało ono wyróżnione nagrodą Rusnanoprize 2013 za Innowacyjny Rozwój. Przyznając nagrodę doceniono BIND za przeniesienie najnowocześniejszej technologii nanocząstkowej na prace nad stadium klinicznym. Ceremonia...
  • 14.12.2013
    Spotkanie przedstawicieli z Chin i Czech i podpisanie memorandium pozwala na zacieśnienie współpracy tych państwo w dziedzinie nanotechnologii. W tym tygodniu przedstawiciele czeskich firm nanotechnologicznych, dwie słynne uczelnie techniczne i CzechInvest wzięły udział w misji technologicznej w Chinach, gdzie spotkały się z chińskimi...
  • 14.12.2013
    BIND Therapeutics, Inc., a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called Accurins™, announced today that it has amended its development and commercialization collaboration agreement with Amgen Inc. to extend the period during which Amgen may exercise its option by six months. BIND...
  • 19.11.2013
    Picosun Oy, the leading Atomic Layer Deposition (ALD) equipment manufacturer, announces the launch of the new PICOSUN™ P-200 batch ALD system. The P-200 ALD tool is specifically optimized for fast and efficient manufacturing of MEMS (MicroElectroMechanical Systems, e.g. sensors and actuators), LEDs (Light-Emitting Diodes), and power...
  • 19.11.2013
    (Nanowerk News) On November 15, Beneq and Saint Petersburg Electrotechnical University (LETI) officially opened the ALD Application Laboratory (ALD AppLab) in St. Petersburg, Russia. The laboratory, a concrete step in boosting thin film research in Russia, is the next step for Beneq in building a notable and ever-growing business around Atomic...
  • 19.11.2013
    Endomagnetics, the company co-founded in the United Kingdom by a University of Houston researcher to develop products to improve the standard of breast cancer care, has been named one of two winners of an inaugural Nanomedicine Award in the European Union.   Endomagnetics was founded to develop and distribute products based on...
  • 19.10.2013
    altFirma Fullerex Limited z dumą ogłasza uruchomienie obsługi handlowej nanomateriałów na platformie INSCXTM. Będzie się ona specjalizować w handlu nanomateriałami, nanoproduktami, polimerami i dwutlenkiem tytanu.   Firma stworzona przez braci Joe i Toma Eldridge zapewnia możliwości rynkowe instytutom badawczym, uznanym dostawcom...
  • 19.10.2013
    Oxford Nanopore Technologies Ltd, the UK-based technology company specialising in nanopore-based electronic molecular analysis systems, has raised £40 million in new funding through a private placement of ordinary shares. The investment was received from new and existing investors in the US, UK and mainland Europe. New investors include...
  • 19.10.2013
    The NanoPlus is a unique instrument that utilizes photon correlation spectroscopy and electrophoretic light scattering techniques to determine particle size and zeta potential. The instrument can measure the particle size of samples suspended in liquids in the range of 0.1 nm to 12.3 µm with sample suspension concentrations from 0.00001%...
  • 23.09.2013
    ZEISS, an international leader in the fields of optics and optoelectronics announced today that the acquisition of U.S.-based Xradia, Inc. has been completed. The closing took place on July 12, 2013 after all formal conditions, as set in the Acquisition Agreement, were fulfilled. Xradia, Inc. is now operating under the new name of Carl Zeiss X-...